Previous investigation demonstrated that phospholipid scramblase 1 (PLSCR1) expression was up‐regulated by wogonoside in 14 of 23 (~61%) of patients with AML [PBMC derived from four relapsed (RR) and 19 newly diagnosed (ND) patients were analysed for PLSCR1 expression using Western blots], suggesting that PLSCR1 acts as an important effector in wogonoside‐treated primary AML cells 17. This evidence concerns the gene PLSCR1 and acute myeloid leukemia.